HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

6- (bromomethylene)tetrahydro- 3- (1- naphthaleneyl)- 2H- pyran- 2- one

structure given in first source; potent irreversible, mechanism-based inhibitor of myocardial calcium-independent phospholipase A2
Also Known As:
6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one; 6-BTNPO; BEL cpd; HELSS; bromoenol lactone
Networked: 24 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Turk, John: 5 articles (07/2012 - 02/2004)
2. Bao, Shunzhong: 4 articles (01/2009 - 02/2004)
3. Zhang, Sheng: 3 articles (07/2011 - 02/2004)
4. Ramanadham, Sasanka: 3 articles (02/2005 - 02/2004)
5. Farooqui, Akhlaq A: 2 articles (06/2015 - 11/2004)
6. Ong, Wei-Yi: 2 articles (06/2015 - 11/2004)
7. Liu, Shu: 2 articles (01/2015 - 07/2012)
8. Jin, Chun: 2 articles (02/2004 - 02/2004)
9. Ma, Zhongmin: 2 articles (02/2004 - 02/2004)
10. Williams, S D: 2 articles (07/2001 - 10/2000)

Related Diseases

1. Hyperalgesia
2. Schizophrenia (Dementia Praecox)
3. Movement Disorders (Movement Disorder)
4. Ischemia
5. Insulinoma

Related Drugs and Biologics

1. Calcium-Independent Phospholipases A2
2. arachidonyltrifluoromethane
3. Carrageenan
4. Secretory Phospholipases A2
5. Phospholipases A2 (Phospholipase A2)
6. Protein Isoforms (Isoforms)
7. Phospholipases (Phospholipase)
8. Calcium
9. Lysophosphatidylcholines (Lysophosphatidylcholine)
10. Insulin (Novolin)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Ligation
3. Spinal Injections